These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria. Alsubaie MA, Alsuheili AZ, Aljehani MN, Alothman AA, Alzahrani AS, Mohammedfadel HA, Alnajjar AA. Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838 [Abstract] [Full Text] [Related]
3. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K. Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [Abstract] [Full Text] [Related]
5. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance. Albaramki JH, Abdelghani T, Dalaeen A, Khdair Ahmad F, Alassaf A, Odeh R, Akl K. Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219 [Abstract] [Full Text] [Related]
6. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections. Mark DG, Hung YY, Salim Z, Tarlton NJ, Torres E, Frazee BW. Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606 [Abstract] [Full Text] [Related]
7. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study. Fernando MM, Luke WA, Miththinda JK, Wickramasinghe RD, Sebastiampillai BS, Gunathilake MP, Silva FH, Premaratna R. BMC Infect Dis; 2017 Feb 10; 17(1):138. PubMed ID: 28187754 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. J Microbiol Immunol Infect; 2011 Oct 10; 44(5):364-8. PubMed ID: 21524974 [Abstract] [Full Text] [Related]
15. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country. Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. PLoS One; 2013 Oct 10; 8(7):e69581. PubMed ID: 23936052 [Abstract] [Full Text] [Related]
17. Risk factors for community acquired urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli in children: a case control study. Zhu FH, Rodado MP, Asmar BI, Salimnia H, Thomas R, Abdel-Haq N. Infect Dis (Lond); 2019 Oct 10; 51(11-12):802-809. PubMed ID: 31429616 [Abstract] [Full Text] [Related]
19. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Infection; 2011 Aug 10; 39(4):333-40. PubMed ID: 21706226 [Abstract] [Full Text] [Related]
20. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years. Aris P, Boroumand MA, Rahbar M, Douraghi M. Microb Drug Resist; 2018 Jun 10; 24(5):607-612. PubMed ID: 29064348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]